4 ms·
It could simply be a challenge to enroll the severe patients in the US depending on their criteria. Tons of patients are ineligible, tons of patients are in ov
by s1artibartfast 7y ago
It could simply be a challenge to enroll the severe patients in the US depending on their criteria. Tons of patients are ineligible, tons of patients are in overloaded hospitals that can't even manage the logistics of procuring masks, let alone a well controlled and documented trial.
Also, they are competing with 265 other trials actively recruiting in the US.
- xiphias2 7y agoIt is very sad that we have 150k dead people in the world (34k in US) who could have produced more than 150x (35x) the data in experiments that weren't controversial, and saved many lives. Still, we'll probably have to wait for targeted medicine to really make a difference.